Mizuho analyst Ann Hynes raised AmerisourceBergen’s target to $104 from $100 and maintained a Neutral rating. Hynes increased the target to reflect the increased earnings outlook, and current clarity on legal matters concerning a potential opioid settlement. She believes the company is recovering well in its core business units and a will receive a boost in revenue from the distribution of the COVID vaccine.
STA Research has a average target of $112.67 on the stock, and a consensus Strong Buy rating. The technical indicator is very bullish.